Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
Intern Med ; 48(14): 1225-9, 2009.
Article in English | MEDLINE | ID: mdl-19602790

ABSTRACT

Aspergillosis of the central nervous system (CNS) is an uncommon infection, mainly occurring in immunocompromised patients. We report a case of nasocerebral aspergillosis in an immunocompetent patient successfully treated with voriconazole and a corticosteroid. Magnetic resonance imaging (MRI) showed contrast enhancement surrounding the brainstem and cerebellum with intramedullary pontine and cerebellar T2-hyperintense lesions. The patient's symptoms and MRI abnormalities improved after voriconazole and corticosteroid treatment; however, discontinuation of the corticosteroid caused a worsening of the T2-hyperintense lesions, whereas resuming it resulted in its improvement. This suggested that these T2-hyperintense lesions may be due to secondary inflammation caused by aspergillosis and not the aspergillosis itself. We conclude that treatment with a combination of voriconazole and a corticosteroid appears to be effective for the treatment of some patients with CNS aspergillosis.


Subject(s)
Antifungal Agents/therapeutic use , Brain Diseases/drug therapy , Brain Diseases/microbiology , Neuroaspergillosis/drug therapy , Pyrimidines/therapeutic use , Triazoles/therapeutic use , Aged , Humans , Immunocompetence , Male , Remission Induction , Voriconazole
SELECTION OF CITATIONS
SEARCH DETAIL
...